ÎÒ¹úÉϺ£¸´µ©´óѧÎ÷ÔÀҽԺѬȾ¿ÆLiµÈ¿ËÈÕÍê³ÉµÄÒ»ÏîÑо¿Åú×¢ £¬ÔÚALTÕý³£»ò¿¿½üÕý³£µÄÂýÐÔÒÒÐ͸ÎÑ×£¨CHB£©»¼ÕßÖÐ £¬Ó¦Óÿ¹-HBc¶¨Á¿Ë®Æ½¿ÉÒÔ׼ȷչÍû»¼ÕߵĸÎÔàÑ×֢ˮƽ¡£Óëµ¥¶ÀÓ¦ÓÃALTˮƽÏà±È £¬ÍŽΌ-HBc¶¨Á¿Ë®Æ½ºÍALTˮƽ½¨ÉèµÄÐÂÖ¸Êý¿ÉÒÔ×÷Ϊ¸ü׼ȷµÄÎÞ´´ÐÔÉúÎï±ê¼ÇÎï £¬ÓÃÓÚÈ·¶¨CHB»¼ÕßµÄÏÔÖøÐÔ¸ÎÔàÑ×Ö¢¡£
¸ÃÏîºá¶ÏÃæÑо¿×ܹ²ÄÉÈë469Àý½ÓÊܸλî¼ìµÄCHB»¼Õß £¬°üÀ¨½¨Ä£×é363ÀýºÍÑéÖ¤×é106Àý £¬¶Ô¿¹-HBc¶¨Á¿Ë®Æ½Óë×é֯ѧºÍѪÇå±ê¼ÇÎïµÄÏà¹ØÐÔ¾ÙÐÐϵͳÆÊÎö £¬ÆÀ¹À¿¹-HBc¶¨Á¿Ë®Æ½ÓÃÓÚÈ·¶¨CHB»¼ÕßÏÔÖøÐÔ¸ÎÔàÑ×Ö¢µÄ¼ÛÖµ¡£
ÔÚ½¨Ä£×éÖÐ £¬¿¹-HBc¶¨Á¿Ë®Æ½¶ÔËùÓл¼ÕßÒÔ¼°ALTˮƽÕý³£»ò¿¿½üÕý³£»¼Õß±£´æÖÐ-ÖضȸÎÔàÑ×Ö¢£¨¡ÝG2£©¾ù¾ßÓÐÓÅÒìµÄÕï¶Ï¼ÛÖµ £¬ÊÜÊÔÕßÊÂÇéÌØÕ÷ÇúÏßÏÂÃæ»ý£¨AUROC£©»®·ÖΪ0.768£¨95%CI£º0.721~0.810 £¬P<0.001£©ºÍ0.767£¨95%CI£º0.697~0.828 £¬P<0.001£©¡£ÔÚËùÓл¼ÕßÖÐ £¬ÍŽΌ-HBc¶¨Á¿Ë®Æ½ºÍALTˮƽ½¨ÉèµÄÐÂÖ¸Êý£¨ACÖ¸Êý£©Óëµ¥¶ÀÓ¦ÓÃALTˮƽÏà±È £¬¶ÔÈ·¶¨Ñ×Ö¢·Ö¼¶¡ÝG2µÄÕï¶ÏÐÔÄÜÏÔÖøÌá¸ß £¬AUROC»®·ÖΪ0.813£¨95%CI£º0.768~0.852£©ºÍ0.779£¨95%CI£º0.732~0.821£©¡£ÔÚÑéÖ¤×éÖÐ £¬ACÖ¸Êý¹ØÓÚËùÓл¼ÕßÒÔ¼°ALTÕý³£»¼ÕßµÄÏÔÖøÐÔ¸ÎÔàÑ×Ö¢¾ùÓнϸߵÄÕï¶Ï¼ÛÖµ £¬AUROC»®·ÖΪ0.890£¨95%CI£º0.814~0.942£©ºÍ0.867£¨95%CI£º0.749~0.943£©¡£
ÔÎÄÁ´½Ó£ºLi J, Zhang TY, Song LW, et al. Role of Quantitative Hepatitis B Core Antibody Levels in Predicting Significant Liver Inflammation in Chronic Hepatitis B Patients with Normal or Near-normal Alanine Aminotransferase Levels. Hepatol Res. 2017 Jul 14.
Ãö¹«Íø°²±¸ 35092602000113ºÅ